Calcium/calmodulin-dependent kinase I and calcium/calmodulin-dependent kinase kinase participate in the control of cell cycle progression in MCF-7 human breast cancer cells

Cancer Research

Volumn 65, Issue 12, 2005, Pages 5408-5416

  Rodriguez Mora, Oswaldo G ^a   LaHair, Michelle M ^a   McCubrey, James A ^a   Franklin, Richard A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PROTEIN KINASE (CALCIUM,CALMODULIN); SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MAMMAL CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

BENZYLAMINES; BREAST NEOPLASMS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL CYCLE; CELL LINE, TUMOR; DOWN-REGULATION; EPITHELIAL CELLS; HUMANS; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; SULFONAMIDES;

EID: 20444439198     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0271     Document Type: Article

References (51)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. Crossman LC, O'Brien SG. Imatinib therapy in chronic myeloid leukemia. Hematol Oncol Clin North Am 2004; 18:605-17; viii.
3. Blagosklonny MV. Gefitinib (Iressa) in oncogene-addictive cancers and therapy for common cancers. Cancer Biol Ther 2004;3:436-40.
4. Ciardiello F, De Vita F, Orditura M, Tortora G. The role of EGFR inhibitors in nonsmall cell Jung cancer. Curr Opin Oncol 2004;16:130-5.
5. Hook SS, Means AR. Ca(2+)/CaM-dependent kinases: from activation to function. Annu Rev Pharmacol Toxicol 2001;41:471-505.
6. 2+/calmodulin-dependent protein kinase kinase. J Biol Chem 1998;273: 21473-81.
7. 2+/calmodulin-dependent protein kinase IV. Identification of a brain CaM-kinase IV kinase. J Biol Chem 1994;269:28640-7.
8. Howe CJ, LaHair MM, Maxwell JA, et al. Participation of the calcium/calmodulin-dependent kinases in hydrogen peroxide-induced IκB phosphorylation in human T lymphocytes. J Biol Chem 2002;277:30469-76.
9. Howe CJ, Lahair MM, McCubrey JA, Franklin RA. Redox regulation of the calcium/calmodulin-dependent protein kinases. J Biol Chem 2004;279:44573-81.
10. Colbran RJ. Targeting of calcium/calmodulin-dependent protein kinase II. Biochem J 2004;378:1-16.
11. 2+/calmodulin-dependent protein kinase kinase β gene encodes multiple isoforms that display distinct kinase activity. J Biol Chem 2001;276: 31113-23.
12. Tombes RM, Krystal GW. Identification of novel human tumor cell-specific CaMK-II variants. Biochim Biophys Acta 1997;1355:281-92.
13. Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 2000;60:3689-95.
14. Kahl CR, Means AR. Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev 2003;24:719-36.
15. Kahl CR, Means AR. Regulation of cyclin D1/Cdk4 complexes by calcium/calmodulin-dependent protein kinase I. J Biol Chem 2004;279:15411-9.
16. Howe CJ, LaHair MM, Robinson PJ, Rodriguez-Mora O, McCubrey JA, Franklin RA. Models of anergy in the human Jurkat T cell line. Assay Drug Dev Technol 2003; 1:537-44.
17. 2/M transition and independently of increased signaling by the JNK/c-Jun pathway. Int J Oncol 2000; 16:413-22.
18. Pauwels B, Korst AE, de Pooter CM, et al. Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies. Cancer Chemother Pharmacol 2003;51:221-6.
19. Hermann M, Lorenz HM, Voll R, Grunke M, Woith W, Kalden JR. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res 1994;22:5506-7.
20. 2+/calmodulin- dependent protein kinase kinase β. J Biol Chem 1998;273:31880-9.
21. 2+/calmodulin-dependent protein kinase kinases in the adult rat brain. Eur J Neurosci 2000;12:89-99.
22. 2+/calmodulin dependent protein kinase cascade in the hog heart. Biochem Biophys Res Commun 1998;249:355-60.
23. Hidaka H, Yokokura H. Molecular and cellular pharmacology of a calcium/calmodulin-dependent protein kinase II (CaM kinase II) inhibitor, KN-62, and proposal of CaM kinase phosphorylation cascades. Adv Pharmacol 1996;36:193-219.
24. Blagosklonny MV, Pardee AB. The restriction point of the cell cycle. Cell Cycle 2002;1:103-10.
25. Foster JS, Henley DC, Ahamed S, Wimalasena J. Estrogens and cell-cycle regulation in breast cancer. Trends Endocrinol Metab 2001;12:320-7.
26. Doisneau-Sixou SF, Sergio CM, Carroll JS, Hui R, Musgrove EA, Sutherland RL. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocr Relat Cancer 2003;10:179-86.
27. Hickie RA, Wei JW, Blyth LM, Wong DY, Klaassen DJ. Cations and calmodulin in normal and neoplastic cell growth regulation. Can J Biochem Cell Biol 1983;61: 934-41.
28. Wei JW, Hickie RA, Klaassen DJ. Inhibition of human breast cancer colony formation by anticalmodulin agents: trifluoperazine, W-7, and W-13. Cancer Chemother Pharmacol 1983;11:86-90.
29. 1/S progression in HeLa cells. Biochem Cell Biol 1995;73:201-7.
30. 2+/CaM kinase). Cell Growth Differ 1995;6:1063-70.
31. 1 arrest in NIH 3T3 cells. Exp Cell Res 1998;240:218-27.
32. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 2004;145:5439-47.
33. Sutherland RL, Musgrove EA. Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models. Breast Cancer Res 2002;4:14-7.
34. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994;57:353-61.
35. Buckley MF, Sweeney KJ, Hamilton JA, et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993;8:2127-33.
36. Gillett C, Fantl V, Smith R, et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994;54: 1812-7.
37. Nielsen NH, Emdin SO, Cajander J, Landberg G. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene 1997;14:295-304.
38. Prall OW, Rogan EM, Musgrove EA, Watts CK, Sutherland RL. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol Cell Biol 1998;18:4499-508.
39. Foster JS, Henley DC, Bukovsky A, Seth P, Wimalasena J. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Mol Cell Biol 2001;21:794-810.
40. Yu Q, Geng Y, Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature 2001;411: 1017-21.
41. Wilcken NR, Prall OW, Musgrove EA, Sutherland RL. Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens. Clin Cancer Res 1997;3:849-54.
42. 1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J Biol Chem 1997;272:10882-94.
43. Ahamed S, Foster JS, Bukovsky A, Wimalasena J. Signal transduction through the Ras/Erk pathway is essential for the mycoestrogen zearalenone-induced cell-cycle progression in MCF-7 cells. Mol Carcinog 2001;30:88-98.
44. Altucci L, Addeo R, Cicatiello L, et al. 17β-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene 1996;12:2315-24.
45. Foster JS, Wimalasena J. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol Endocrinol 1996;10:488-98.
46. Soderling TR. The Ca-calmodulin-dependent protein kinase cascade. Trends Biochem Sci 1999;24:232-6.
47. Boulon S, Dantonel JC, Binet V, et al. Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB- and CREB binding protein-independent mechanism. Mol Cell Biol 2002;22:7769-79.
48. Schmitt JM, Wayman GA, Nozaki N, Soderling TR. Calcium activation of ERK mediated by calmodulin kinase I. J Biol Chem 2004;279:24064-72.
49. 2+/CaM-dependent protein kinases required for normal nuclear division in Aspergillus nidulans. J Biol Chem 2000;275:38230-8.
50. 2+/calmodulin-dependent protein kinase II: localization in the interphase nucleus and the mitotic apparatus of mammalian cells. Proc Natl Acad Sci U S A 1990;87:5341-5.
51. 2/M phase transition in HeLa cells. J Biol Chem 1999;274:7958-68.